ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant, Medical

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,556Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 66

$525K Total Retail Price of All Prescriptions

Rank: 3 out of 66

812 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 812 patients filled at least one prescription for a schedule two drug, compared to an average of 23%.

Schedule Three
Controlled Substances

4% of this provider’s 812 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,100 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $108 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 7.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 230 184 1 17
LEVOTHYROXINE SODIUM 224 179 2 7
SIMVASTATIN 204 166 3 9
AMLODIPINE BESYLATE 198 181 4 6
ATORVASTATIN CALCIUM 168 158 5 18
LISINOPRIL 167 138 6 4
METOPROLOL SUCCINATE 161 154 7 40
METOPROLOL TARTRATE 150 115 8 23
PANTOPRAZOLE SODIUM 140 123 9 46
SERTRALINE HCL 138 111 10 47
ZOLPIDEM TARTRATE 133 100 11 27
PRAVASTATIN SODIUM 115 103 12 10
DONEPEZIL HCL 114 114 13 52
CRESTOR 110 105 14 32
METFORMIN HCL 108 76 15 13
POTASSIUM CHLORIDE 104 94 16 55
HYDROCHLOROTHIAZIDE 100 81 17 22
TRAMADOL HCL 98 79 18 19
CLONIDINE HCL 95 85 19 57
GABAPENTIN 92 82 20 8
OMEPRAZOLE 74 67 21 29
DIOVAN 71 63 22 62
FENOFIBRATE 71 57 22 62
NEXIUM 70 34 24 64
ATENOLOL 68 53 25 66
OXYCODONE-ACETAMINOPHEN 67 36 S2 26 14
TAMSULOSIN HCL 66 55 27 67
CITALOPRAM HBR 64 52 28 69
ADVAIR DISKUS 64 51 28 69
CARVEDILOL 61 51 30 41
ESCITALOPRAM OXALATE 61 59 30 72
FLUTICASONE PROPIONATE 61 50 30 37
PROAIR HFA 59 46 33 75
LEVOFLOXACIN 57 38 34 78
AZITHROMYCIN 57 40 34 78
NAMENDA 57 57 34 78
METFORMIN HCL ER 56 41 37 82
GLIPIZIDE ER 56 38 37 82
FENTANYL 55 52 S2 39 11
RANITIDINE HCL 54 28 40 34
LOSARTAN POTASSIUM 53 52 41 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.